These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 9205749)

  • 1. Metabolism of ebrotidine. A review.
    Rozman E; Albet C; Sacristán A; Ortiz JA
    Arzneimittelforschung; 1997 Apr; 47(4A):486-9. PubMed ID: 9205749
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Physicochemical properties, analytical determinations and stability of ebrotidine.
    Albet C; Fernández JM; Castelló JM; Sacristán A; Ortiz JA
    Arzneimittelforschung; 1997 Apr; 47(4A):435-8. PubMed ID: 9205739
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Investigation of the metabolism of ebrotidine in human urine by liquid chromatography-atmospheric pressure chemical ionization mass spectrometry.
    Rozman E; Galceran MT; Anglada L; Albet C
    Drug Metab Dispos; 1995 Sep; 23(9):976-81. PubMed ID: 8565788
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetic study of ebrotidine administered in multiple doses to healthy volunteers for 4 days.
    Frías J; Esteban C; Carcas AJ; Sánchez-García P; Albet C; Torres J; Márquez M; Ortiz JA
    Arzneimittelforschung; 1997 Apr; 47(4A):531-4. PubMed ID: 9205759
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetics of ebrotidine in healthy volunteers. A summary.
    Albet C; Pérez JA; Rozman E; Márquez M; Herrero E; Ortiz JA
    Arzneimittelforschung; 1997 Apr; 47(4A):535-9. PubMed ID: 9205760
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metabolites of ebrotidine, a new H2-receptor antagonist, in human urine.
    Rozman E; Galcerán MT; Anglada L; Albet C
    J Pharm Sci; 1994 Feb; 83(2):252-4. PubMed ID: 7909553
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Determination of ebrotidine and its metabolites in human urine by reversed-phase ion-pair high-performance liquid chromatography.
    Rozman E; Galcerán MT; Albet C
    J Chromatogr B Biomed Sci Appl; 1997 Jan; 688(1):107-15. PubMed ID: 9029320
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ebrotidine and its metabolites studied by mass spectrometry with electrospray ionization. Comparison of tandem and in-source fragmentation..
    Rozman E; Galcerán MT; Albet C
    Rapid Commun Mass Spectrom; 1995; 9(15):1492-8. PubMed ID: 8652876
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Continuous intragastric pH monitoring in the evaluation of ebrotidine, cimetidine and placebo on gastric acidity in healthy volunteers.
    Muñoz-Navas M; Honorato J; Reina-Ariño M; Márquez M; Herrero E; Villamayor F; Torres J; Roset PN; Fíllat O; Camps F; Ortiz JA
    Arzneimittelforschung; 1997 Apr; 47(4A):539-44. PubMed ID: 9205761
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tolerability and pharmacokinetics of ebrotidine in healthy subjects given single and repeated oral doses.
    Farré M; Roset PN; Badenas JM; Ugena B; Márquez M; Albet C; Herrero E; Ortiz JA
    Arzneimittelforschung; 1997 Apr; 47(4A):528-30. PubMed ID: 9205758
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Determination of ebrotidine and its metabolites by capillary electrophoresis with UV and mass spectrometry detection.
    Sentellas S; Puignou L; Moyano E; Galceran MT
    J Chromatogr A; 2000 Aug; 888(1-2):281-92. PubMed ID: 10949494
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-Helicobacter pylori activities of ebrotidine. A review of biochemical and animal experimental studies and data.
    Slomiany BL; Piotrowski J; Slomiany A
    Arzneimittelforschung; 1997 Apr; 47(4A):475-82. PubMed ID: 9205747
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of the efficacy and safety of ebrotidine in the treatment of duodenal ulcer. A multicentre, double-blind, placebo-controlled phase II study.
    Gabryelewicz A; Czajkowski A; Skrodzka D; Marlicz K; Luca de Tena F; Aldeguer M; Chantar C; Márquez M; Torres J; Ortiz JA
    Arzneimittelforschung; 1997 Apr; 47(4A):545-50. PubMed ID: 9205762
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Studies on the protective effect of ebrotidine on experimental ulcers induced by non-steroidal anti-inflammatory drugs in healthy volunteers.
    Puscas I; Puscas C; Coltau M; Torres J; Márquez M; Herrero E; Fillat O; Ortiz JA
    Arzneimittelforschung; 1997 Apr; 47(4A):565-8. PubMed ID: 9205766
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of ebrotidine on ethanol-induced gastric mucosal damage in the rat. Comparative study with other H2-receptor antagonists.
    Palop D; Romero A; Villamayor F; Conejo L; Sacristán A; Ortiz JA
    Arzneimittelforschung; 1997 Apr; 47(4A):450-4. PubMed ID: 9205742
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gastroprotective properties of ebrotidine. A review.
    Slomiany BL; Piotrowski J; Slomiany A
    Arzneimittelforschung; 1997 Apr; 47(4A):459-67. PubMed ID: 9205744
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of ebrotidine and ranitidine in the treatment of benign gastric ulcer.
    Gedliczka O; Bobrzynski A; Rembiasz K; Fillat O; Torres J; Herrero E; Márquez M; Camps F; Ortiz JA
    Arzneimittelforschung; 1997 Apr; 47(4A):560-4. PubMed ID: 9205765
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Action of ebrotidine, ranitidine and cimetidine on the specific binding to histamine H1- and H2-receptors.
    Agut J; Sánchez JC; Sacristán A; Ortiz JA
    Arzneimittelforschung; 1997 Apr; 47(4A):447-9. PubMed ID: 9205741
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Determination of ebrotidine and its metabolites by micellar electrokinetic capillary chromatography.
    Sentellas S; Puignou L; Galceran MT
    J Chromatogr A; 2002 Nov; 976(1-2):221-7. PubMed ID: 12462613
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ebrotidine versus ranitidine in the healing and prevention of relapse of duodenal ulcer. A multicentre, double-blind, parallel, randomized, controlled study.
    Tulassay Z; Döbrönte Z; Farkas I; Juhász L; Simon L; Prónai L; Torres J; Márquez M
    Arzneimittelforschung; 1997 Apr; 47(4A):551-5. PubMed ID: 9205763
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.